"von Willebrand Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.
Descriptor ID |
D014842
|
MeSH Number(s) |
C15.378.100.100.900 C15.378.100.141.900 C15.378.140.900 C15.378.463.920 C16.320.099.920
|
Concept/Terms |
von Willebrand Diseases- von Willebrand Diseases
- Hemophilia, Vascular
- Vascular Hemophilia
- Vascular Hemophilias
- Vascular Pseudohemophilia
- Pseudohemophilia, Vascular
- Pseudohemophilias, Vascular
- Vascular Pseudohemophilias
- Von Willebrand's Factor Deficiency
- Von Willebrand Disorder
- Disorder, Von Willebrand
- von Willebrand's Disease
- von Willebrand's Diseases
- Angiohemophilia
- Angiohemophilias
- von Willebrand Disease
|
Below are MeSH descriptors whose meaning is more general than "von Willebrand Diseases".
Below are MeSH descriptors whose meaning is more specific than "von Willebrand Diseases".
This graph shows the total number of publications written about "von Willebrand Diseases" by people in this website by year, and whether "von Willebrand Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "von Willebrand Diseases" by people in Profiles.
-
Chang IJ, Byers HM, Ng BG, Merritt JL, Gilmore R, Shrimal S, Wei W, Zhang Y, Blair AB, Freeze HH, Zhang B, Lam C. Factor VIII and vWF deficiency in STT3A-CDG. J Inherit Metab Dis. 2019 03; 42(2):325-332.
-
Hassan SA, Amer S, Qureshi W, Alirhayim Z, Kuriakose P. Treating symptomatic coronary artery disease in patients with Von Willebrand disease. Hematol Oncol Stem Cell Ther. 2013 Sep-Dec; 6(3-4):101-4.
-
Qureshi W, Hassan S, Dabak V, Kuriakose P. Thrombosis in VonWillebrand disease. Thromb Res. 2012 Nov; 130(5):e255-8.
-
Braverman PK, Breech L. Management quandary. Menorrhagia in a teenager: Von Willebrand disease type 1. J Pediatr Adolesc Gynecol. 2004 Feb; 17(1):61-4.
-
Perkins SJ, Hinshelwood J, Edwards YJ, Jenkins PV. Structural and functional modelling of von Willebrand factor type A domains in complement and coagulation. Biochem Soc Trans. 1999 Dec; 27(6):815-20.
-
Mannucci PM, Schimpf K, Abe T, Aledort LM, Anderle K, Brettler DB, Hilgartner MW, Kernoff PB, Kunschak M, McMillan CW, et al. Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator Group. Transfusion. 1992 Feb; 32(2):134-8.
-
Andrews CA, Sullivan JL, Brettler DB, Brewster FE, Forsberg AD, Scesney S, Levine PH. Isolation of human immunodeficiency virus from hemophiliacs: correlation with clinical symptoms and immunologic abnormalities. J Pediatr. 1987 Nov; 111(5):672-7.